Document Detail


Cervical Shirodkar cerclage may be the treatment modality of choice for cervical pregnancy.
MedLine Citation:
PMID:  11821302     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Our objective was to evaluate the use of cervical suture in cervical pregnancy. METHODS AND RESULTS: All cases of cervical pregnancy diagnosed and treated in the gynaecological department at the Sheba Medical Center between 1994-2000 were included in the study. Eight such cases were diagnosed. The first four cases were treated medically. The last four cases (the study group) of cervical pregnancy, including one case of heterotopic pregnancy, were treated successfully with placement of Shirodkar cerclage. CONCLUSION: Cervical cerclage may be considered as the treatment of choice in cases of cervical pregnancies. It may be the only therapy in cases of heterotopic pregnancies (intrauterine and cervical pregnancy).
Authors:
Shlomo Mashiach; Dahlia Admon; Gabriel Oelsner; Baram Paz; R Achiron; Yaron Zalel
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  17     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2002 Feb 
Date Detail:
Created Date:  2002-01-31     Completed Date:  2002-04-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  493-6     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / adverse effects*
Adult
Cerclage, Cervical*
Cervix Uteri / ultrasonography
Female
Humans
Methotrexate / adverse effects
Middle Aged
Pregnancy
Pregnancy Outcome
Pregnancy, Ectopic / drug therapy,  surgery*,  ultrasonography
Uterine Hemorrhage / surgery
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum vascular endothelial growth factor as a possible marker for early ectopic pregnancy.
Next Document:  Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 dia...